Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2015-11-06
Original SEC Filing: Click here

---

Webplus: SVA/20151106/6-K/2_EX-99.1/000.htm SEC Original: v423979_ex99-1.htm
Sinovac to Host Conference Call to Report Third Quarter 2015 Unaudited Financial Results BEIJING, Nov. 2, 2015 /PRNewswire/ — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the third quarter, ended September 30, 2015, after the market closes on Wednesday, November 11, 2015. The

---

---

Webplus: SVA/20151106/6-K/3_EX-99.2/000.htm SEC Original: v423979_ex99-2.htm
Sinovac to Participate in Morgan Stanley Asia Pacific Summit th BEIJING, November 4, 2015 — Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced that the Company’s management will participate in the 14 About Sinovac www.sinovac.com Sinovac Biotech Ltd. is a China-based biopharmaceutical company that focuses on the research, development, manufacturing, and commercialization of vaccines

---

---

Webplus: SVA/20151106/6-K/1/000.htm SEC Original: v423979_6k.htm

---

Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2015-11-06CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085